JPRN-UMIN000034118已完成未知
Study on the influence of Topiroxostat on renal function - Study on the influence of Topiroxostat on renal function
Sato Clinic0 个研究点目标入组 59 人开始时间: 2018年9月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 59
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with history of hemodialysis or peritoneal dialysis within 3 months before or after the administration of topiroxostat, or before eGFR of less than 30, or before the start date of topioxastat administration 2. Patients taking other uric acid-lowering drugs (Febuxostat, Allopurinol, Benzbromarone, Probenecid, Bucolome) (including switching from other uric acid lowering drugs)
研究者
相似试验
尚未招募
不适用
The effect of topiroxostat on renal function in type2 diabetes with hyperuricemiatype 2 diabetes with serum uric acid levels more than 7 mg/dl and eGFR more than 60 mL/min/1.73m2JPRN-UMIN000022644Osaka City University Graduate School of Medicine20
已完成
不适用
Influence of febuxostat and Topiroxostat on renal functiohyperuricemiaJPRN-UMIN000014771Sekino Hospital50
已完成
不适用
The effect of topirxostat on hemodialysis patient with hyperuricemiahyperuricemiaJPRN-UMIN000026620TM50
已完成
不适用
Effect of topiroxostat on diabetic nephropathy in patients with type 2 diabetes mellitusJPRN-UMIN000038238Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University20
已完成
不适用
Influence of febuxostat and allopurinol on renal function for hyperuricemiaHyperuricemic patients (Uric acid>8.0mg/dL)JPRN-UMIN000005964ihon University School of Medicine140